Politics, Policy & Law


<div class="articleContainer">
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title" doc-editable="text" data-component-id="doc-1ef7l320d0">FDA to stop reviewing COVID-19 lab tests, raising concerns in Congress&#xA0;</h1><h2 class="title-bottom" doc-editable="title" data-component-id="doc-1ek2h40cf0">As agency drops voluntary reviews of LDT EUAs, lawmakers worry about accuracy of tests</h2><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1ef7l3fol0">
    <span class="ng-tns-c17-4" doc-editable="text">By STeve Usdin, Washington Editor</span>
</div><div class="date">October 7, 2020 8:24 PM GMT</div></div></div></div>


U.S. Food and Drug Administration (FDA)

cov19pol

FDA to stop reviewing COVID-19 lab tests, raising concerns in Congress 

As agency drops voluntary reviews of LDT EUAs, lawmakers worry about accuracy of tests.

As agency drops voluntary reviews of LDT EUAs, lawmakers worry about accuracy of tests

Featured Analysis

Articles

Current Editions

Data Graphics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

Events

My Workspace

Company Overview

Management

Editorial & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home